Navigation Links
Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome
Date:12/29/2011

ular Atrial Fibrillation: Discontinuing XARELTO®, in the absence of adequate alternative anticoagulation, increases the risk of thrombotic events. An increased rate of stroke was observed during the transition from XARELTO® to warfarin in clinical trials in atrial fibrillation patients. If XARELTO® must be discontinued for a reason other than pathological bleeding, consider administering another anticoagulant.
  • Risk of Bleeding: XARELTO® increases the risk of bleeding and can cause serious or fatal bleeding. In deciding whether to prescribe XARELTO® to patients at increased risk of bleeding, the risk of thrombotic events should be weighed against the risk of bleeding. Promptly evaluate any signs or symptoms of blood loss. Discontinue XARELTO® in patients with active pathological hemorrhage.
    • A specific antidote for rivaroxaban is not available. Because of high plasma protein binding, rivaroxaban is not expected to be dialyzable. Protamine sulfate and vitamin K are not expected to affect the anticoagulant activity of rivaroxaban. There is no experience with antifibrinolytic agents (tranexamic acid, aminocaproic acid) in individuals receiving rivaroxaban. There is neither scientific rationale for benefit nor experience with systemic hemostatics (desmopressin and aprotinin) in individuals receiving rivaroxaban. Use of procoagulant reversal agents such as prothrombin complex concentrate (PCC), activated prothrombin complex concentrate (APCC), or recombinant factor VIIa (rFVIIa) may be considered, but has not been evaluated in clinical trials.
    • Concomitant use of drugs affecting hemostasis increases the risk of bleeding. These include aspirin, P2Y12 platelet inhibitors, other antithrombotic agents, fibrinolytic therapy, and NSAIDs.
    • Concomitant use of drugs that are combined P-gp and CYP3
      '/>"/>

    SOURCE Janssen Research & Development, LLC
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Record Breaking $327 Million Verdict Upheld in Janssen Case and Request for New Trial Denied
    2. Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations
    3. Pharmacyclics Forms Pact to Develop and Commercialize PCI-32765 for Hematologic Cancers with Janssen Biotech, Inc.
    4. Janssen Pharmaceuticals, Inc. Launches Online Tools on PrescribeResponsibly.com
    5. Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division
    6. Dr. Napoleone Ferrara Wins 2011 Dr. Paul Janssen Award for Biomedical Research
    7. Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease
    8. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
    9. Record Breaking $327 Million Verdict Announced in Janssen Case
    10. MHPA Center for Best Practices Receives Sponsorship from Ortho-McNeil Janssen Pharmaceuticals, Inc. to Improve Medicaid Quality, Care Coordination for Serious Mental Illness
    11. Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/27/2015)... KING OF PRUSSIA, Pa. , Feb. 27, 2015 ... part of its ongoing commitment to the global bleeding ... it is donating 2 million international units (IUs) of ... WFH is an international not-for- profit organization which has ... and other inherited bleeding disorders. The donation supports the ...
    (Date:2/27/2015)... TEL-AVIV, Israel , February 27, 2015 ... Unternehmen baut sein bahnbrechendes Überwachungssystem für kongestive ... weiter aus -   ... Medical Technologies, die ein neuartiges Herzüberwachungssystem für ... gab heute bekannt, dass sie ein Finanzierungsvorhaben ...
    (Date:2/27/2015)... 2015  Two mass spectrometry technologies MALDI ... their effectiveness is established, according to biotechnology ... says that while mass spectrometry (mass spec ... in proteomic biomarker discovery and validation, mass ... techniques has struggled to elucidate molecular distribution ...
    Breaking Medicine Technology:CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3
    ... Mich., Jan. 23, 2012  Researchers at the University of ... and found that less expensive, more effective tests are ... of patients receiving neuropathy diagnoses undergo high-cost, low-yield MRIs ... according to the study that will be published Jan. ...
    ... FALLS, N.Y., Jan. 23, 2012  Niagara Thermal Products LLC ... & Sons, Inc. The acquisition brings together two highly ... value custom thermal solutions in the aerospace, defense and ... ) "The addition of Kittredge,s industry recognized ...
    Cached Medicine Technology:Neuropathy Patients More Likely to Receive High-cost, Low-yield Screening Instead of More Effective Tests 2Neuropathy Patients More Likely to Receive High-cost, Low-yield Screening Instead of More Effective Tests 3Niagara Thermal Products LLC Announces the Acquisition of J. Kittredge & Sons, Inc. 2Niagara Thermal Products LLC Announces the Acquisition of J. Kittredge & Sons, Inc. 3
    (Date:2/28/2015)... February 28, 2015 The noted Friedman ... that they have officially relaunched their website. The new ... but it contains a new section about their team ... read the full biographies of each Friedman Dental Group ... the website was designed to provide our patients with ...
    (Date:2/28/2015)... Javon Bea Mercy Health System CEO ... stroke capable by the State of Illinois, enabling potential ... Harvard Hospital. , The hospital was required to submit ... treat stroke according to national standards of care for ... to bypass hospitals not designated as an Emergent Stroke ...
    (Date:2/28/2015)... Memphis, TN: MedixSafe has retracted a previous ... security reader named Guardian 2. The correct product ... biometric scanner that significantly increases the complexity of ... biometric scanner provides fast and easy access for ... narcotics lockers with Vanguard technology tracks inventory ...
    (Date:2/28/2015)... 28, 2015 1Heart Caregiver Services ... emerging brand at Houston Texas Franchise Expo South ... sending its executive delegates headed by Vice-President of ... and Training Randolph Clarito. , Franchise Expo South, ... last February 4-7 and featured Franchise brands of ...
    (Date:2/27/2015)... 27, 2015 OnChip Devices , ... introduced miniature, wire bondable, silicon ESD (Electrostatic Discharge) protection ... The ESD88NP and ESD88PN ... sensitive LED and IC products. These Zeners exhibit ... All devices meet the requirements of IEC61000 and ...
    Breaking Medicine News(10 mins):Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 3Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3
    ... a neurobiological side to it. A new study suggests ... ,David Erritzoe and his colleagues at Copenhagen University ... normal weight and 29 overweight people. They found that ... the neurotransmitter serotonin than those of normal weight, reported ...
    ... methods of treatment in Urogynaecology will be the focus ... on Urogynaecology and Reconstructive pelvic surgery, that begins here ... of a pelvic surgery, being conducted at Government Kasturba ... ,,Briefing reporters about the three-day conference, Dr ...
    ... emirate will start a health insurance policy next month which ... companies that fall under the Phase 1 category will be ... which will make the lowest paid the first to benefit ... of the General Authority for Health Services (GAHS) in Abu ...
    ... has come up in Kolkata to contain Diarrheal diseases in ... one of the best of its kind equipped with the ... Minister for Health & Family Welfare, Dr. Anbumani Ramadoss, will ... named the 'Diarrheal Research and Control Centre' (DRCC) in the ...
    ... to Dr. Alexis Carrel digestive wastes which become stagnant in our ... 1911 for his discovery that growing live tissue cells can be ... not removed for three days then the cells become weak and ... meal that one eats. ,Studies have shown that if ...
    ... NHS news it is said that the breast cancer drug Herceptin ... But this is not happy news to the grieving family of ... cancer. But NHS officials denied her the drug which led to ... ,By profession she was an advertising art director from Wimbledon, ...
    Cached Medicine News:Health News:Health Minister Inaugurates Institute for Diarrhea Diseases 2
    Auto Refkeratomoeter...
    ... Management System answers the day-to-day needs ... flexibility. From programming to data retrieval, ... management right where you want it. ... to help each patient become ambulatory ...
    ... can be customized with selectable performance parameters ... and therapies. The COLLEAGUE pumps allow ... used for both gravity and pump regulation, ... simple infusions to medication therapies requiring complex ...
    ChildLab is a service of Children's Hospital, Columbus Ohio...
    Medicine Products: